• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-氯白花丹醌通过丝裂原活化蛋白激酶介导的髓细胞白血病-1抑制作用诱导乳腺癌细胞死亡。

3-Chloroplumbagin Induces Cell Death in Breast Cancer Cells Through MAPK-Mediated Mcl-1 Inhibition.

作者信息

Kawiak Anna, Domachowska Anna, Krolicka Aleksandra, Smolarska Monika, Lojkowska Ewa

机构信息

Department of Biotechnology, Intercollegiate Faculty of Biotechnology UG and MUG, University of Gdansk, Gdansk, Poland.

出版信息

Front Pharmacol. 2019 Jul 26;10:784. doi: 10.3389/fphar.2019.00784. eCollection 2019.

DOI:10.3389/fphar.2019.00784
PMID:31404252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6675870/
Abstract

Resistance acquired toward anti-cancer agents is a significant drawback in breast cancer therapy. A key factor contributing to drug resistance is apoptosis suppression associated with the upregulation of anti-apoptotic Bcl-2 family proteins. Specifically, the anti-apoptotic Mcl-1 protein has been shown to play a significant role in drug resistance, making it an important therapeutic target. The present study aimed at determining the antiproliferative activity of 3-chloroplumbagin (ChPL), a naphthoquinone derived from a sp., toward breast cancer cells and examining the involvement of Mcl-1 inhibition in ChPL-induced cell death. The results showed that ChPL inhibited breast cancer cell proliferation and induced apoptosis through the intrinsic pathway through down-regulation of anti-apoptotic Bcl-2 family proteins. The induction of apoptosis by ChPL was found to be mediated through MAP kinase signaling inhibition. ChPL inhibited the phosphorylation of MEK and ERK proteins in breast cancer cells, and increased apoptosis induction in cells with reduced ERK expression. Furthermore, ERK silencing decreased the expression of Mcl-1 in ChPL-treated cells. The results of this research indicate that ChPL induces apoptosis in breast cancer cells through MAPK-mediated Mcl-1 inhibition, suggesting further research into its potential in breast cancer treatment.

摘要

对抗癌药物产生耐药性是乳腺癌治疗中的一个重大缺陷。导致耐药性的一个关键因素是与抗凋亡Bcl-2家族蛋白上调相关的细胞凋亡抑制。具体而言,抗凋亡蛋白Mcl-1已被证明在耐药性中起重要作用,使其成为一个重要的治疗靶点。本研究旨在确定3-氯石蒜醌(ChPL)(一种从 属植物中提取的萘醌)对乳腺癌细胞的抗增殖活性,并研究抑制Mcl-1在ChPL诱导的细胞死亡中的作用。结果表明,ChPL通过下调抗凋亡Bcl-2家族蛋白,抑制乳腺癌细胞增殖并通过内源性途径诱导细胞凋亡。发现ChPL诱导的细胞凋亡是通过抑制MAP激酶信号传导介导的。ChPL抑制乳腺癌细胞中MEK和ERK蛋白的磷酸化,并增加ERK表达降低的细胞中的细胞凋亡诱导。此外,ERK沉默降低了ChPL处理细胞中Mcl-1的表达。本研究结果表明,ChPL通过MAPK介导的Mcl-1抑制诱导乳腺癌细胞凋亡,提示对其在乳腺癌治疗中的潜力进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/200cfdfc467e/fphar-10-00784-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/c4bea1863621/fphar-10-00784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/879cf351ce52/fphar-10-00784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/71c3cc7cfb7e/fphar-10-00784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/eb3dcfde6a2f/fphar-10-00784-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/6b431dc4476c/fphar-10-00784-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/200cfdfc467e/fphar-10-00784-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/c4bea1863621/fphar-10-00784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/879cf351ce52/fphar-10-00784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/71c3cc7cfb7e/fphar-10-00784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/eb3dcfde6a2f/fphar-10-00784-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/6b431dc4476c/fphar-10-00784-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aec/6675870/200cfdfc467e/fphar-10-00784-g006.jpg

相似文献

1
3-Chloroplumbagin Induces Cell Death in Breast Cancer Cells Through MAPK-Mediated Mcl-1 Inhibition.3-氯白花丹醌通过丝裂原活化蛋白激酶介导的髓细胞白血病-1抑制作用诱导乳腺癌细胞死亡。
Front Pharmacol. 2019 Jul 26;10:784. doi: 10.3389/fphar.2019.00784. eCollection 2019.
2
Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.拉门他酮,一种源自茅膏菜属植物的萘醌,通过抑制乳腺癌细胞中的PI3K/Akt信号通路诱导细胞凋亡。
PLoS One. 2016 Feb 3;11(2):e0147718. doi: 10.1371/journal.pone.0147718. eCollection 2016.
3
Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.在MCF-7人乳腺癌中,通过操纵信号转导途径诱导的细胞毒性与Bcl-2的下调有关,但与Mcl-1的下调无关。
Breast Cancer Res Treat. 2001 Nov;70(1):11-20. doi: 10.1023/a:1012564620853.
4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.白花丹素通过 ERK 介导的细胞凋亡诱导增加紫杉醇诱导的细胞死亡并克服乳腺癌细胞中的紫杉醇耐药性。
J Nat Prod. 2019 Apr 26;82(4):878-885. doi: 10.1021/acs.jnatprod.8b00964. Epub 2019 Feb 27.
5
Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.通过抑制MEK诱导人黑色素瘤细胞凋亡不依赖于半胱天冬酶,且由Bcl-2家族成员PUMA、Bim和Mcl-1介导。
Clin Cancer Res. 2007 Aug 15;13(16):4934-42. doi: 10.1158/1078-0432.CCR-07-0665. Epub 2007 Jul 25.
6
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.内在凋亡途径的激活增加了对腔面乳腺癌中抗雌激素药物的反应。
Cell Death Dis. 2018 Jan 17;9(2):21. doi: 10.1038/s41419-017-0072-x.
7
A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.一种新型BH3模拟物通过直接结合抗凋亡Bcl-2家族蛋白(包括磷酸化的Mcl-1)有效诱导黑色素瘤细胞凋亡。
Pigment Cell Melanoma Res. 2015 Mar;28(2):161-70. doi: 10.1111/pcmr.12325. Epub 2014 Dec 18.
8
Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.小干扰RNA下调mcl-1可使耐药黑色素瘤细胞对fas介导的凋亡敏感。
Mol Cancer Res. 2008 Jan;6(1):42-52. doi: 10.1158/1541-7786.MCR-07-0080.
9
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells.同时靶向MCL-1和ERK1/2激酶可诱导横纹肌肉瘤细胞发生线粒体凋亡。
Transl Oncol. 2022 Feb;16:101313. doi: 10.1016/j.tranon.2021.101313. Epub 2021 Dec 11.
10
Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.下调 Mcl-1 表达增强细胞凋亡作用:塞来昔布提高光动力疗法疗效的证据。
Exp Cell Res. 2013 Jun 10;319(10):1491-504. doi: 10.1016/j.yexcr.2013.03.012. Epub 2013 Mar 22.

引用本文的文献

1
Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review.白花丹素在癌症和代谢紊乱中的药理作用及治疗意义:综述。
Nutrients. 2024 Sep 8;16(17):3033. doi: 10.3390/nu16173033.
2
Biological Potential of Carnivorous Plants from Nepenthales.食虫植物的生物学潜力——来自瓶子草科。
Molecules. 2023 Apr 21;28(8):3639. doi: 10.3390/molecules28083639.
3
Carnivorous Plants from Nepenthaceae and Droseraceae as a Source of Secondary Metabolites.猪笼草科和茅膏菜科的食虫植物作为次生代谢产物的来源。

本文引用的文献

1
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.白花丹素通过 ERK 介导的细胞凋亡诱导增加紫杉醇诱导的细胞死亡并克服乳腺癌细胞中的紫杉醇耐药性。
J Nat Prod. 2019 Apr 26;82(4):878-885. doi: 10.1021/acs.jnatprod.8b00964. Epub 2019 Feb 27.
2
Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.白花丹素通过抑制葡萄糖调节蛋白 78(GRP78)和上调 Bik 蛋白使乳腺癌细胞对他莫昔芬诱导的细胞死亡敏感。
Sci Rep. 2017 Mar 13;7:43781. doi: 10.1038/srep43781.
3
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Molecules. 2023 Feb 24;28(5):2155. doi: 10.3390/molecules28052155.
4
Progress in understanding the mechanisms of resistance to BCL-2 inhibitors.对BCL-2抑制剂耐药机制的理解进展。
Exp Hematol Oncol. 2022 May 21;11(1):31. doi: 10.1186/s40164-022-00283-0.
5
Myeloid cell leukemia-1 expression in cancers of the oral cavity: a scoping review.口腔癌中髓样细胞白血病-1的表达:一项范围综述
Cancer Cell Int. 2022 May 6;22(1):182. doi: 10.1186/s12935-022-02603-0.
6
Transformation of nomifensine using ionizing radiation and exploration of its anticancer effects in MCF-7 cells.诺米芬辛的电离辐射转化及其对MCF-7细胞的抗癌作用探索。
Exp Ther Med. 2022 Apr;23(4):306. doi: 10.3892/etm.2022.11235. Epub 2022 Feb 23.
7
Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy.雌激素受体阳性乳腺癌中Bcl-2家族蛋白的调控及其在内分泌治疗中的意义
Cancers (Basel). 2022 Jan 7;14(2):279. doi: 10.3390/cancers14020279.
8
Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach.通过综合生物信息学方法鉴定临床乳腺癌患者中的二肽基肽酶(DPP)家族基因
Diagnostics (Basel). 2021 Jul 2;11(7):1204. doi: 10.3390/diagnostics11071204.
9
Transformed tissue of Dionaea muscipula J. Ellis as a source of biologically active phenolic compounds with bactericidal properties.捕蝇草(Dionaea muscipula J. Ellis)转化组织作为具有杀菌特性的生物活性酚类化合物的来源。
Appl Microbiol Biotechnol. 2021 Feb;105(3):1215-1226. doi: 10.1007/s00253-021-11101-8. Epub 2021 Jan 15.
10
Elicitation-Based Method for Increasing the Production of Antioxidant and Bactericidal Phenolic Compounds in J. Ellis Tissue.基于启发式方法提高 J. Ellis 组织中抗氧化和杀菌酚类化合物的产量。
Molecules. 2020 Apr 14;25(8):1794. doi: 10.3390/molecules25081794.
Mcl-1赋予人表皮生长因子受体2阳性乳腺癌细胞对缺氧的保护作用:治疗意义
Breast Cancer Res. 2016 Feb 26;18(1):26. doi: 10.1186/s13058-016-0686-4.
4
Discovery and resupply of pharmacologically active plant-derived natural products: A review.药理活性植物源天然产物的发现与再供应:综述
Biotechnol Adv. 2015 Dec;33(8):1582-1614. doi: 10.1016/j.biotechadv.2015.08.001. Epub 2015 Aug 15.
5
Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?Bcl-2家族蛋白在乳腺发育和癌症中的作用:靶向Mcl-1能否克服治疗耐药性?
Oncotarget. 2015 Feb 28;6(6):3519-30. doi: 10.18632/oncotarget.2792.
6
Combination of silver nanoparticles and Drosera binata extract as a possible alternative for antibiotic treatment of burn wound infections caused by resistant Staphylococcus aureus.银纳米颗粒与二齿茅膏菜提取物的组合作为耐药金黄色葡萄球菌引起的烧伤创面感染抗生素治疗的一种可能替代方案。
PLoS One. 2014 Dec 31;9(12):e115727. doi: 10.1371/journal.pone.0115727. eCollection 2014.
7
Plumbagin modulates leukemia cell redox status.白花丹醌调节白血病细胞的氧化还原状态。
Molecules. 2014 Jul 10;19(7):10011-32. doi: 10.3390/molecules190710011.
8
Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.抗癌植物化学类似物37:新型白花丹素腙对乳腺癌细胞的合成、表征、分子对接及细胞毒性
Bioorg Med Chem Lett. 2014 Jul 1;24(13):2900-4. doi: 10.1016/j.bmcl.2014.04.100. Epub 2014 May 4.
9
The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.Bcl-2/xL抑制剂ABT-263可提高肝癌细胞中Mcl-1 mRNA和蛋白的稳定性。
Mol Cancer. 2014 Apr 30;13:98. doi: 10.1186/1476-4598-13-98.
10
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.新辅助化疗后三阴性乳腺癌残留病灶的分子特征分析可确定可采取行动的治疗靶点。
Cancer Discov. 2014 Feb;4(2):232-45. doi: 10.1158/2159-8290.CD-13-0286. Epub 2013 Dec 19.